We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Color Changing Pigments Identify Infectious Bacteria

By LabMedica International staff writers
Posted on 09 May 2011
Print article
Image: Colorimetric sensor array of several pathogens (Photo courtesy of University of Illinois).
Image: Colorimetric sensor array of several pathogens (Photo courtesy of University of Illinois).
An inexpensive scanner coupled with color changing pigments can be used to identify infectious bacteria by their smell, according to a new study.

Researchers at the University of Illinois (Urbana-Champaign, USA) used a disposable colorimetric sensor array for the rapid identification of both species and specific strains of human pathogenic bacteria grown on standard agar, using the volatile gases they produce. The researchers spread blood samples on Petri dishes of a standard growth gel, attached an array to the inside of the lid of each dish, and then inverted the dishes onto an ordinary flatbed scanner. Every 30 minutes, they scanned the arrays and recorded the color changes in each dot; the pattern of color change over time is unique to each bacterium.

In only a few hours, the array not only confirmed the presence of bacteria, but identified specific species and strain. All 10 strains of bacteria tested, including Enterococcus faecalis and Staphylococcus aureus and their antibiotic-resistant forms, were identified with 98.8% accuracy within 10 hours, a clinically important time frame. Furthermore, the colorimetric sensor arrays also proved useful as a simple research tool for the study of bacterial metabolism, and as an easy method for the optimization of bacterial production of fine chemicals or other fermentation processes. The array can even recognize antibiotic resistance, a key factor in treatment decisions. The study was published in the April 27, 2011, issue of the Journal of the American Chemical Society.

"The progression of the pattern change is part of the diagnosis of which bacteria it is," said lead author Kenneth Suslick, PhD, who also cofounded iSense Systems, the company which is commercializing the array technology for clinical use. "It's like time-lapse photography. You're not looking just at a single frame; you're looking at the motion of the frames over time."

Related Links:

University of Illinois


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.